img

Global Medication Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Medication Market Insights, Forecast to 2034

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Market Analysis and InsightsGlobal Medication Market
Global Medication market is expected to reach to US$ 1548750 million in 2024, with a positive growth of %, compared with US$ 1475000 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Medication industry is evaluated to reach US$ 2075470 million in 2029. The CAGR will be 5.0% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Medication market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Medication market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
AbbVie
Takeda
Boehringer Ingelheim
Segment by Type
Brand Drugs
Generic Drug

Segment by Application


Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Medication introduction, etc. Medication Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Medication
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Brand Drugs
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medication Market Perspective (2018-2029)
2.2 Global Medication Growth Trends by Region
2.2.1 Medication Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Medication Historic Market Size by Region (2018-2024)
2.2.3 Medication Forecasted Market Size by Region (2024-2029)
2.3 Medication Market Dynamics
2.3.1 Medication Industry Trends
2.3.2 Medication Market Drivers
2.3.3 Medication Market Challenges
2.3.4 Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Medication by Players
3.1.1 Global Medication Revenue by Players (2018-2024)
3.1.2 Global Medication Revenue Market Share by Players (2018-2024)
3.2 Global Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Medication, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Medication Market Concentration Ratio
3.4.1 Global Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medication Revenue in 2022
3.5 Global Key Players of Medication Head office and Area Served
3.6 Global Key Players of Medication, Product and Application
3.7 Global Key Players of Medication, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Medication Breakdown Data by Type
4.1 Global Medication Historic Market Size by Type (2018-2024)
4.2 Global Medication Forecasted Market Size by Type (2024-2029)
5 Medication Breakdown Data by Application
5.1 Global Medication Historic Market Size by Application (2018-2024)
5.2 Global Medication Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Medication Market Size (2018-2029)
6.2 North America Medication Market Size by Type
6.2.1 North America Medication Market Size by Type (2018-2024)
6.2.2 North America Medication Market Size by Type (2024-2029)
6.2.3 North America Medication Market Share by Type (2018-2029)
6.3 North America Medication Market Size by Application
6.3.1 North America Medication Market Size by Application (2018-2024)
6.3.2 North America Medication Market Size by Application (2024-2029)
6.3.3 North America Medication Market Share by Application (2018-2029)
6.4 North America Medication Market Size by Country
6.4.1 North America Medication Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Medication Market Size by Country (2018-2024)
6.4.3 North America Medication Market Size by Country (2024-2029)
6.4.4 the United States
6.4.5 Canada
7 Europe
7.1 Europe Medication Market Size (2018-2029)
7.2 Europe Medication Market Size by Type
7.2.1 Europe Medication Market Size by Type (2018-2024)
7.2.2 Europe Medication Market Size by Type (2024-2029)
7.2.3 Europe Medication Market Share by Type (2018-2029)
7.3 Europe Medication Market Size by Application
7.3.1 Europe Medication Market Size by Application (2018-2024)
7.3.2 Europe Medication Market Size by Application (2024-2029)
7.3.3 Europe Medication Market Share by Application (2018-2029)
7.4 Europe Medication Market Size by Country
7.4.1 Europe Medication Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Medication Market Size by Country (2018-2024)
7.4.3 Europe Medication Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Medication Market Size (2018-2029)
8.2 China Medication Market Size by Type
8.2.1 China Medication Market Size by Type (2018-2024)
8.2.2 China Medication Market Size by Type (2024-2029)
8.2.3 China Medication Market Share by Type (2018-2029)
8.3 China Medication Market Size by Application
8.3.1 China Medication Market Size by Application (2018-2024)
8.3.2 China Medication Market Size by Application (2024-2029)
8.3.3 China Medication Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Medication Market Size (2018-2029)
9.2 Asia Medication Market Size by Type
9.2.1 Asia Medication Market Size by Type (2018-2024)
9.2.2 Asia Medication Market Size by Type (2024-2029)
9.2.3 Asia Medication Market Share by Type (2018-2029)
9.3 Asia Medication Market Size by Application
9.3.1 Asia Medication Market Size by Application (2018-2024)
9.3.2 Asia Medication Market Size by Application (2024-2029)
9.3.3 Asia Medication Market Share by Application (2018-2029)
9.4 Asia Medication Market Size by Region
9.4.1 Asia Medication Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Medication Market Size by Region (2018-2024)
9.4.3 Asia Medication Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Medication Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Medication Market Size by Type
10.2.1 Middle East, Africa, and Latin America Medication Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Medication Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Medication Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Medication Market Size by Application
10.3.1 Middle East, Africa, and Latin America Medication Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Medication Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Medication Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Medication Market Size by Country
10.4.1 Middle East, Africa, and Latin America Medication Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Medication Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Medication Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Medication Introduction
11.1.4 Pfizer Revenue in Medication Business (2018-2024)
11.1.5 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Medication Introduction
11.2.4 Roche Revenue in Medication Business (2018-2024)
11.2.5 Roche Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Medication Introduction
11.3.4 Sanofi Revenue in Medication Business (2018-2024)
11.3.5 Sanofi Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Medication Introduction
11.4.4 Johnson & Johnson Revenue in Medication Business (2018-2024)
11.4.5 Johnson & Johnson Recent Developments
11.5 Merck & Co. (MSD)
11.5.1 Merck & Co. (MSD) Company Details
11.5.2 Merck & Co. (MSD) Business Overview
11.5.3 Merck & Co. (MSD) Medication Introduction
11.5.4 Merck & Co. (MSD) Revenue in Medication Business (2018-2024)
11.5.5 Merck & Co. (MSD) Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Medication Introduction
11.6.4 Novartis Revenue in Medication Business (2018-2024)
11.6.5 Novartis Recent Developments
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Medication Introduction
11.7.4 AbbVie Revenue in Medication Business (2018-2024)
11.7.5 AbbVie Recent Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Medication Introduction
11.8.4 Gilead Sciences Revenue in Medication Business (2018-2024)
11.8.5 Gilead Sciences Recent Developments
11.9 GlaxoSmithKline (GSK)
11.9.1 GlaxoSmithKline (GSK) Company Details
11.9.2 GlaxoSmithKline (GSK) Business Overview
11.9.3 GlaxoSmithKline (GSK) Medication Introduction
11.9.4 GlaxoSmithKline (GSK) Revenue in Medication Business (2018-2024)
11.9.5 GlaxoSmithKline (GSK) Recent Developments
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Medication Introduction
11.10.4 Amgen Revenue in Medication Business (2018-2024)
11.10.5 Amgen Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Medication Introduction
11.11.4 AstraZeneca Revenue in Medication Business (2018-2024)
11.11.5 AstraZeneca Recent Developments
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Details
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Medication Introduction
11.12.4 Bristol-Myers Squibb Revenue in Medication Business (2018-2024)
11.12.5 Bristol-Myers Squibb Recent Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Medication Introduction
11.13.4 Eli Lilly Revenue in Medication Business (2018-2024)
11.13.5 Eli Lilly Recent Developments
11.14 Teva
11.14.1 Teva Company Details
11.14.2 Teva Business Overview
11.14.3 Teva Medication Introduction
11.14.4 Teva Revenue in Medication Business (2018-2024)
11.14.5 Teva Recent Developments
11.15 Bayer
11.15.1 Bayer Company Details
11.15.2 Bayer Business Overview
11.15.3 Bayer Medication Introduction
11.15.4 Bayer Revenue in Medication Business (2018-2024)
11.15.5 Bayer Recent Developments
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Details
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Medication Introduction
11.16.4 Novo Nordisk Revenue in Medication Business (2018-2024)
11.16.5 Novo Nordisk Recent Developments
11.17 AbbVie
11.17.1 AbbVie Company Details
11.17.2 AbbVie Business Overview
11.17.3 AbbVie Medication Introduction
11.17.4 AbbVie Revenue in Medication Business (2018-2024)
11.17.5 AbbVie Recent Developments
11.18 Takeda
11.18.1 Takeda Company Details
11.18.2 Takeda Business Overview
11.18.3 Takeda Medication Introduction
11.18.4 Takeda Revenue in Medication Business (2018-2024)
11.18.5 Takeda Recent Developments
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Details
11.19.2 Boehringer Ingelheim Business Overview
11.19.3 Boehringer Ingelheim Medication Introduction
11.19.4 Boehringer Ingelheim Revenue in Medication Business (2018-2024)
11.19.5 Boehringer Ingelheim Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Medication Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Brand Drugs
Table 3. Key Players of Generic Drug
Table 4. Global Medication Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Medication Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Medication Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Medication Market Share by Region (2018-2024)
Table 8. Global Medication Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Medication Market Share by Region (2024-2029)
Table 10. Medication Market Trends
Table 11. Medication Market Drivers
Table 12. Medication Market Challenges
Table 13. Medication Market Restraints
Table 14. Global Medication Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Medication Revenue Share by Players (2018-2024)
Table 16. Global Top Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication as of 2022)
Table 17. Global Medication Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Medication Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Medication, Headquarters and Area Served
Table 20. Global Key Players of Medication, Product and Application
Table 21. Global Key Players of Medication, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Medication Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Medication Revenue Market Share by Type (2018-2024)
Table 25. Global Medication Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Medication Revenue Market Share by Type (2024-2029)
Table 27. Global Medication Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Medication Revenue Share by Application (2018-2024)
Table 29. Global Medication Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Medication Revenue Share by Application (2024-2029)
Table 31. North America Medication Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Medication Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Medication Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Medication Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Medication Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Medication Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Medication Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Medication Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Medication Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Medication Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Medication Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Medication Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Medication Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Medication Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Medication Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Medication Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Medication Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Medication Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Medication Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Medication Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Medication Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Medication Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Medication Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Medication Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Medication Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Medication Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Medication Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Medication Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Medication Market Size by Country (2024-2029) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Medication Product
Table 66. Pfizer Revenue in Medication Business (2018-2024) & (US$ Million)
Table 67. Pfizer Recent Developments
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Medication Product
Table 71. Roche Revenue in Medication Business (2018-2024) & (US$ Million)
Table 72. Roche Recent Developments
Table 73. Sanofi Company Details
Table 74. Sanofi Business Overview
Table 75. Sanofi Medication Product
Table 76. Sanofi Revenue in Medication Business (2018-2024) & (US$ Million)
Table 77. Sanofi Recent Developments
Table 78. Johnson & Johnson Company Details
Table 79. Johnson & Johnson Business Overview
Table 80. Johnson & Johnson Medication Product
Table 81. Johnson & Johnson Revenue in Medication Business (2018-2024) & (US$ Million)
Table 82. Johnson & Johnson Recent Developments
Table 83. Merck & Co. (MSD) Company Details
Table 84. Merck & Co. (MSD) Business Overview
Table 85. Merck & Co. (MSD) Medication Product
Table 86. Merck & Co. (MSD) Revenue in Medication Business (2018-2024) & (US$ Million)
Table 87. Merck & Co. (MSD) Recent Developments
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Medication Product
Table 91. Novartis Revenue in Medication Business (2018-2024) & (US$ Million)
Table 92. Novartis Recent Developments
Table 93. AbbVie Company Details
Table 94. AbbVie Business Overview
Table 95. AbbVie Medication Product
Table 96. AbbVie Revenue in Medication Business (2018-2024) & (US$ Million)
Table 97. AbbVie Recent Developments
Table 98. Gilead Sciences Company Details
Table 99. Gilead Sciences Business Overview
Table 100. Gilead Sciences Medication Product
Table 101. Gilead Sciences Revenue in Medication Business (2018-2024) & (US$ Million)
Table 102. Gilead Sciences Recent Developments
Table 103. GlaxoSmithKline (GSK) Company Details
Table 104. GlaxoSmithKline (GSK) Business Overview
Table 105. GlaxoSmithKline (GSK) Medication Product
Table 106. GlaxoSmithKline (GSK) Revenue in Medication Business (2018-2024) & (US$ Million)
Table 107. GlaxoSmithKline (GSK) Recent Developments
Table 108. Amgen Company Details
Table 109. Amgen Business Overview
Table 110. Amgen Medication Product
Table 111. Amgen Revenue in Medication Business (2018-2024) & (US$ Million)
Table 112. Amgen Recent Developments
Table 113. AstraZeneca Company Details
Table 114. AstraZeneca Business Overview
Table 115. AstraZeneca Medication Product
Table 116. AstraZeneca Revenue in Medication Business (2018-2024) & (US$ Million)
Table 117. AstraZeneca Recent Developments
Table 118. Bristol-Myers Squibb Company Details
Table 119. Bristol-Myers Squibb Business Overview
Table 120. Bristol-Myers Squibb Medication Product
Table 121. Bristol-Myers Squibb Revenue in Medication Business (2018-2024) & (US$ Million)
Table 122. Bristol-Myers Squibb Recent Developments
Table 123. Eli Lilly Company Details
Table 124. Eli Lilly Business Overview
Table 125. Eli Lilly Medication Product
Table 126. Eli Lilly Revenue in Medication Business (2018-2024) & (US$ Million)
Table 127. Eli Lilly Recent Developments
Table 128. Teva Company Details
Table 129. Teva Business Overview
Table 130. Teva Medication Product
Table 131. Teva Revenue in Medication Business (2018-2024) & (US$ Million)
Table 132. Teva Recent Developments
Table 133. Bayer Company Details
Table 134. Bayer Business Overview
Table 135. Bayer Medication Product
Table 136. Bayer Revenue in Medication Business (2018-2024) & (US$ Million)
Table 137. Bayer Recent Developments
Table 138. Novo Nordisk Company Details
Table 139. Novo Nordisk Business Overview
Table 140. Novo Nordisk Medication Product
Table 141. Novo Nordisk Revenue in Medication Business (2018-2024) & (US$ Million)
Table 142. Novo Nordisk Recent Developments
Table 143. AbbVie Company Details
Table 144. AbbVie Business Overview
Table 145. AbbVie Medication Product
Table 146. AbbVie Revenue in Medication Business (2018-2024) & (US$ Million)
Table 147. AbbVie Recent Developments
Table 148. Takeda Company Details
Table 149. Takeda Business Overview
Table 150. Takeda Medication Product
Table 151. Takeda Revenue in Medication Business (2018-2024) & (US$ Million)
Table 152. Takeda Recent Developments
Table 153. Boehringer Ingelheim Company Details
Table 154. Boehringer Ingelheim Business Overview
Table 155. Boehringer Ingelheim Medication Product
Table 156. Boehringer Ingelheim Revenue in Medication Business (2018-2024) & (US$ Million)
Table 157. Boehringer Ingelheim Recent Developments
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Medication Market Share by Type: 2022 VS 2029
Figure 3. Brand Drugs Features
Figure 4. Generic Drug Features
Figure 5. Global Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Medication Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Medication Report Years Considered
Figure 11. Global Medication Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Medication Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Medication Market Share by Region: 2022 VS 2029
Figure 14. Global Medication Market Share by Players in 2022
Figure 15. Global Top Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Medication Revenue in 2022
Figure 17. North America Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Medication Market Share by Type (2018-2029)
Figure 19. North America Medication Market Share by Application (2018-2029)
Figure 20. North America Medication Market Share by Country (2018-2029)
Figure 21. United States Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Medication Market Share by Type (2018-2029)
Figure 25. Europe Medication Market Share by Application (2018-2029)
Figure 26. Europe Medication Market Share by Country (2018-2029)
Figure 27. Germany Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Medication Market Share by Type (2018-2029)
Figure 35. China Medication Market Share by Application (2018-2029)
Figure 36. Asia Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Medication Market Share by Type (2018-2029)
Figure 38. Asia Medication Market Share by Application (2018-2029)
Figure 39. Asia Medication Market Share by Region (2018-2029)
Figure 40. Japan Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Medication Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Medication Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Medication Market Share by Country (2018-2029)
Figure 50. Brazil Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Pfizer Revenue Growth Rate in Medication Business (2018-2024)
Figure 57. Roche Revenue Growth Rate in Medication Business (2018-2024)
Figure 58. Sanofi Revenue Growth Rate in Medication Business (2018-2024)
Figure 59. Johnson & Johnson Revenue Growth Rate in Medication Business (2018-2024)
Figure 60. Merck & Co. (MSD) Revenue Growth Rate in Medication Business (2018-2024)
Figure 61. Novartis Revenue Growth Rate in Medication Business (2018-2024)
Figure 62. AbbVie Revenue Growth Rate in Medication Business (2018-2024)
Figure 63. Gilead Sciences Revenue Growth Rate in Medication Business (2018-2024)
Figure 64. GlaxoSmithKline (GSK) Revenue Growth Rate in Medication Business (2018-2024)
Figure 65. Amgen Revenue Growth Rate in Medication Business (2018-2024)
Figure 66. AstraZeneca Revenue Growth Rate in Medication Business (2018-2024)
Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Medication Business (2018-2024)
Figure 68. Eli Lilly Revenue Growth Rate in Medication Business (2018-2024)
Figure 69. Teva Revenue Growth Rate in Medication Business (2018-2024)
Figure 70. Bayer Revenue Growth Rate in Medication Business (2018-2024)
Figure 71. Novo Nordisk Revenue Growth Rate in Medication Business (2018-2024)
Figure 72. AbbVie Revenue Growth Rate in Medication Business (2018-2024)
Figure 73. Takeda Revenue Growth Rate in Medication Business (2018-2024)
Figure 74. Boehringer Ingelheim Revenue Growth Rate in Medication Business (2018-2024)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries